100 related articles for article (PubMed ID: 23146434)
1. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
[TBL] [Abstract][Full Text] [Related]
2. PD-1/PD-L1 pathway and angiogenesis dual recognizable nanoparticles for enhancing chemotherapy of malignant cancer.
Sun Z; Zhang Y; Cao D; Wang X; Yan X; Li H; Huang L; Qu X; Kong C; Qin H; Wang M; Xu W; Liang L
Drug Deliv; 2018 Nov; 25(1):1746-1755. PubMed ID: 30394118
[TBL] [Abstract][Full Text] [Related]
3. Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.
Liu Y; Mei L; Xu C; Yu Q; Shi K; Zhang L; Wang Y; Zhang Q; Gao H; Zhang Z; He Q
Theranostics; 2016; 6(2):177-91. PubMed ID: 26877777
[TBL] [Abstract][Full Text] [Related]
4. Development of tLyP-1 functionalized nanoliposomes with tunable internal water phase for glioma targeting.
Wang Y; Ding Z; Lv S; Liu J; Pan J; Yu Y; Gao J; Huang X
J Liposome Res; 2023 Dec; 33(4):353-367. PubMed ID: 36974836
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma.
Wang R; Wang X; Zhao H; Li N; Li J; Zhang H; Di L
J Control Release; 2024 Jan; 365():331-347. PubMed ID: 38000664
[TBL] [Abstract][Full Text] [Related]
6. Modulation of hydrogel nanoparticle intracellular trafficking by multivalent surface engineering with tumor targeting peptide.
Karamchand L; Kim G; Wang S; Hah HJ; Ray A; Jiddou R; Koo Lee YE; Philbert MA; Kopelman R
Nanoscale; 2013 Nov; 5(21):10327-44. PubMed ID: 24056573
[TBL] [Abstract][Full Text] [Related]
7. Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.
Negron K; Khalasawi N; Lu B; Ho CY; Lee J; Shenoy S; Mao HQ; Wang TH; Hanes J; Suk JS
J Control Release; 2019 Jun; 303():1-11. PubMed ID: 30978431
[TBL] [Abstract][Full Text] [Related]
8. Improve BBB Penetration and Cytotoxicity of Palbociclib in U87-MG Glioblastoma Cells Delivered by Dual Peptide Functionalized Nanoparticles.
Lo YC; Lin WJ
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896189
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-controlled tumor penetrating peptide.
Braun GB; Sugahara KN; Yu OM; Kotamraju VR; Mölder T; Lowy AM; Ruoslahti E; Teesalu T
J Control Release; 2016 Jun; 232():188-95. PubMed ID: 27106816
[TBL] [Abstract][Full Text] [Related]
10. Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma.
Cheng Y; Muroski ME; Petit DCMC; Mansell R; Vemulkar T; Morshed RA; Han Y; Balyasnikova IV; Horbinski CM; Huang X; Zhang L; Cowburn RP; Lesniak MS
J Control Release; 2016 Feb; 223():75-84. PubMed ID: 26708022
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles.
Lv L; Li X; Qian W; Li S; Jiang Y; Xiong Y; Xu J; Lv W; Liu X; Chen Y; Tang Y; Xin H
Front Pharmacol; 2020; 11():558. PubMed ID: 32425792
[TBL] [Abstract][Full Text] [Related]
12. Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.
Dzhumashev D; Anton-Joseph S; Morel VJ; Timpanaro A; Bordon G; Piccand C; Aleandri S; Luciani P; Rössler J; Bernasconi M
Eur J Pharm Biopharm; 2024 Jan; 194():49-61. PubMed ID: 38029941
[TBL] [Abstract][Full Text] [Related]
13. Click conjugation of peptide to hydrogel nanoparticles for tumor-targeted drug delivery.
Qin M; Zong H; Kopelman R
Biomacromolecules; 2014 Oct; 15(10):3728-34. PubMed ID: 25162488
[TBL] [Abstract][Full Text] [Related]
14. Tumor penetrating peptides for improved drug delivery.
Ruoslahti E
Adv Drug Deliv Rev; 2017 Feb; 110-111():3-12. PubMed ID: 27040947
[TBL] [Abstract][Full Text] [Related]
15. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J
Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain.
Hamilton AM; Aidoudi-Ahmed S; Sharma S; Kotamraju VR; Foster PJ; Sugahara KN; Ruoslahti E; Rutt BK
J Mol Med (Berl); 2015 Sep; 93(9):991-1001. PubMed ID: 25869026
[TBL] [Abstract][Full Text] [Related]
18. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
[TBL] [Abstract][Full Text] [Related]
19. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.
Liang DS; Zhang WJ; Wang AT; Su HT; Zhong HJ; Qi XR
Biomaterials; 2017 Aug; 137():23-36. PubMed ID: 28528300
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
